Professional Summary
Professional Overview
John Drakenberg is the Founder and CEO of Alex Therapeutics, a Stockholm-based startup disrupting the healthcare industry through innovative digital solutions. With over 15 years of experience in product development, business strategy, and executive search, John brings a unique blend of entrepreneurial vision and industry expertise to his role.
Experience Summary
Current Role
As the Founder and CEO of Alex Therapeutics, John is responsible for driving the company's strategic direction, overseeing product development, and leading a talented team of healthcare and technology professionals. Under his leadership, the company has rapidly grown to become a recognized leader in the digital therapeutics space, developing groundbreaking solutions that improve patient outcomes and streamline healthcare delivery.
Career Progression
Prior to founding Alex Therapeutics, John held various executive-level positions, including a role as a C-Suite Executive Headhunter at the prestigious Russell Reynolds Associates, where he played a key role in identifying and placing top talent within the healthcare and technology sectors. Earlier in his career, he gained valuable experience in product and business development at Happyr, a leading EdTech startup, as well as in marketing at the renowned advertising agency, StrawberryFrog.
John's entrepreneurial journey began with the founding of Arista Education, a successful education technology company, which he led as CEO from 2005 to 2012, establishing it as a prominent player in the digital learning space.
Academic Background
John holds a Bachelor's degree in Business Administration from the Stockholm School of Economics, where he graduated with distinction and was recognized for his academic excellence.
Areas of Expertise
- Digital health and healthcare technology
- Product development and innovation
- Business strategy and growth
- Executive leadership and team management
- Talent identification and executive search
Professional Impact
Under John's visionary leadership, Alex Therapeutics has emerged as a trailblazer in the digital therapeutics industry, developing cutting-edge solutions that have garnered widespread recognition and acclaim. The company's flagship product, a personalized digital therapy platform for chronic disease management, has been adopted by leading healthcare providers, delivering measurable improvements in patient outcomes and significant cost savings for the healthcare system.
Conclusion
John Drakenberg's impressive professional journey, spanning entrepreneurship, executive leadership, and industry-shaping innovations, positions him as a dynamic and forward-thinking leader in the healthcare technology space. With a proven track record of success and a steadfast commitment to driving positive change, John is poised to continue making a meaningful impact on the future of digital health.
